Effect of Pilocarpine mouthwash on diabetic patients xerostomia

Phase 3

• Conditions: Dry mouth(xerostomia).; Disturbances of salivary secretion; K11.7

• Registration Number: IRCT20220930056061N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Having diabetes mellitus according to the diagnostic criteria of the American Diabetes Association
Suffering from dry mouth according to the diagnosis based on the questionnaire of Fox et al
desire and physical and mental ability to cooperate and use mouthwash correctly

Exclusion Criteria

History of uncontrolled asthma
History of gastric ulcer
Reluctance to cooperate with the study
Acute or chronic use of medicine or mouthwash used to relieve dry mouth
History of autoimmune disease
Head and neck radiation therapy
Infection with human immunodeficiency virus(HIV), hepatitis type B and hepatitis type C
using of drugs effecting on the amount of saliva during the trial

Study & Design

• Study Type: interventional
• Study Design: Not specified